KidneyCAN Program Director, Melissa Derr, is on the Hill today visiting congressional offices before the House Defense Appropriations bill is drafted.
We are reminding key offices of our FY27 request: restore funding for the Kidney Cancer Research Program to $50 million.
This funding is essential to advancing kidney cancer research, supporting scientific discovery, and accelerating cures for patients and families.
KidneyCan visits the offices of Representatives Aderholt, Calvert, Fleischmann, Carter, Valadao, Ellzey, Tome Cole, Womack, Joyce, and Diaz-Balart to keep kidney cancer research visible and urgent as funding decisions move forward.
